
Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of Elevated Infliximab Concentrations
Author(s) -
Ryan C. Ungaro,
Jean Fréd́eric Colombel,
Marla Dubinsky,
Anjali Jain,
Thierry Dervieux
Publication year - 2021
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izab232
Subject(s) - thiopurine methyltransferase , infliximab , medicine , azathioprine , immunogenicity , mercaptopurine , biosimilar , inflammatory bowel disease , monoclonal antibody , immunology , crohn's disease , pharmacology , antibody , tumor necrosis factor alpha , gastroenterology , disease